Results 21 to 30 of about 37,745 (95)

Molecular mechanisms related to colistin resistance in Enterobacteriaceae

Infection and Drug Resistance, 2019
Colistin is an effective antibiotic for treatment of most multidrug-resistant Gram-negative bacteria. It is used currently as a last-line drug for infections due to severe Gram-negative bacteria followed by an increase in resistance among Gram-negative ...
Zahra Aghapour, P. Gholizadeh, K. Ganbarov, Abed Zahedi Bialvaei, S. S. Mahmood, A. Tanomand, M. Yousefi, M. Asgharzadeh, B. Yousefi, H. Kafil   +9 more
semanticscholar   +1 more source

Enterobacteriaceae in the Human Gut: Dynamics and Ecological Roles in Health and Disease

Biology
Simple Summary The human gastrointestinal tract harbors a complex and dynamic population of microorganisms (mostly bacteria and viruses) that are called the gut microbiota. This microbial community is known to exert a marked influence on the host health.
Maria Ines Moreira de Gouveia, Annick Bernalier-Donadille, Grégory Jubelin   +2 more
semanticscholar   +1 more source

Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion

Science, 2017
Healthy guts exclude oxygen Normally, the lumen of the colon lacks oxygen. Fastidiously anaerobic butyrate-producing bacteria thrive in the colon; by ablating these organisms, antibiotic treatment removes butyrate. Byndloss et al. discovered that loss of
M. Byndloss, Erin E. Olsan, Fabian Rivera-Chávez, Connor R. Tiffany, Stephanie A. Cevallos, Kristen L Lokken, Teresa P. Torres, Austin J Byndloss, F. Faber, Yandong Gao, Yael Litvak, Christopher A. Lopez, Gege Xu, E. Napoli, C. Giulivi, R. Tsolis, A. Revzin, C. Lebrilla, A. Bäumler   +18 more
semanticscholar   +1 more source

Extended-spectrum beta-lactamase production and multi-drug resistance among Enterobacteriaceae isolated in Addis Ababa, Ethiopia

Antimicrobial Resistance and Infection Control, 2019
The global emergence and spread of extended-spectrum beta-lactamases (ESBLs) producing Enterobacteriaceae have been threatening the ability to treat an infection.
D. S. Teklu, Abebe A Negeri, Melese Hailu Legese, T. Bedada, Hiwot Ketema Woldemariam, K. Tullu   +5 more
semanticscholar   +1 more source

Endogenous Enterobacteriaceae underlie variation in susceptibility to Salmonella infection

Nature Microbiology, 2019
Lack of reproducibility is a prominent problem in biomedical research. An important source of variation in animal experiments is the microbiome, but little is known about specific changes in the microbiota composition that cause phenotypic differences ...
Eric M Velazquez, Henry Nguyen, Keaton T. Heasley, Cheng Saechao, Lindsey M. Gil, Andrew W. L. Rogers, Brittany M. Miller, M. Rolston, Christopher A. Lopez, Yael Litvak, Megan J. Liou, F. Faber, Denise N. Bronner, Connor R. Tiffany, M. Byndloss, Austin J Byndloss, A. Bäumler   +16 more
semanticscholar   +1 more source

Plasmid evolution in carbapenemase‐producing Enterobacteriaceae: a review

Annals of the New York Academy of Sciences, 2019
Carbapenem‐resistant Enterobacteriaceae (CRE) have been listed by the WHO as high‐priority pathogens owing to their high association with mortalities and morbidities.
K. Kopotsa, John Osei Sekyere, N. Mbelle
semanticscholar   +1 more source

Identification of Enterobacteriaceae by the automicrobic system: Enterobacteriaceae biochemical cards versus Enterobacteriaceae-plus biochemical cards [PDF]

Journal of Clinical Microbiology, 1982
Enterobacteriaceae Biochemical Cards (EBC) may be used in the AutoMicrobic system for identification of enteric bacilli. Recently, the card has been modified to permit identification of enteric and certain nonenteric bacilli. Also, minor modifications have been in the computer program used for interpretation of tests with the new cards (EBC+).
R E Badal, A L Barry
openaire   +3 more sources

Plazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae.

New England Journal of Medicine, 2019
Plazomicin for Severe Resistant Infection This report compared plazomicin with colistin for the treatment of severe (bloodstream or pneumonia) infection with carbapenem-resistant Enterobacteriaceae...
J. McKinnell, J. Dwyer, G. Talbot, L. Connolly, I. Friedland, Alex Smith, A. Jubb, A. Serio, K. Krause, G. Daikos   +9 more
semanticscholar   +1 more source

Worsening epidemiological situation of carbapenemase-producing Enterobacteriaceae in Europe, assessment by national experts from 37 countries, July 2018

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2019
A survey on the epidemiological situation, surveillance and containment activities for carbapenemase-producing Enterobacteriaceae (CPE) was conducted in European countries in 2018. All 37 participating countries reported CPE cases.
A. Brolund, N. Lagerqvist, Sara Byfors, M. Struelens, D. Monnet, B. Albiger, A. Kohlenberg   +6 more
semanticscholar   +1 more source

Escalating antimicrobial resistance among Enterobacteriaceae: focus on carbapenemases

Expert Opinion on Pharmacotherapy, 2021
Introduction: Over the past few decades, antimicrobial resistance (AMR) has skyrocketed globally among bacteria within the Family Enterobacteriaceae (i.e.
J. Lynch, N. Clark, G. Zhanel
semanticscholar   +1 more source